KPP
GRDN

Kings Path Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Kings Path Partners’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Hold
10,300
– – 0.11% 74
2026
Q1 		$388K Hold
10,300
– – 0.13% 74
2025
Q4 		$310K Buy
+10,300
New +$291K 0.11% 84

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Kings Path Partners's GRDN Position: Q2 2026 in Review

Kings Path Partners held its Guardian Pharmacy Services (GRDN) position steady in Q2 2026 at 10,300 shares worth $431K. The position accounts for 0.11% of the portfolio, ranked #74.

Kings Path Partners first reported a position in GRDN in Q4 2025 and has held it in 3 quarters since. 189 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Kings Path Partners held 10,300 shares of Guardian Pharmacy Services worth $431K as of Q2 2026.
  • Kings Path Partners left its Guardian Pharmacy Services share count unchanged in Q2 2026.
  • Guardian Pharmacy Services made up 0.11% of Kings Path Partners's portfolio in Q2 2026, its #74 holding.
  • Kings Path Partners first reported a position in Guardian Pharmacy Services in Q4 2025 and has held it in 3 quarters since.
  • 189 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.